Celltrion (KRX: 068270)

Celltrion is a corporation based in Incheon, South Korea. Established in 2002, the company is engaged in the research, development, and manufacture of therapeutic proteins. The company manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others. The assets of the company are managed by the board of directors.